
Chemours (CC) Stock Forecast & Price Target
Chemours (CC) Analyst Ratings
Bulls say
The Chemours Company is experiencing positive growth trajectories across its operating segments, particularly in Thermal & Specialized Solutions (TSS) where the adoption of HFO (Opteon) is driving sales growth and production expansion. Additionally, the Titanium Technologies (TT) segment is benefiting from year-over-year volume increases and a successful transformation initiative that has exceeded initial cost-saving expectations, potentially yielding up to $200 million by year-end. Moreover, Chemours is strategically positioned to capitalize on market dynamics in Europe, where anti-dumping measures may support volume recovery and stabilize pricing in the TiO2 market following recent cost forecasts.
Bears say
The Chemours Company faces significant challenges that contribute to a negative outlook on its stock, primarily due to anticipated destocking in its Advanced Performance Materials segment, which is expected to lag the TiO2 market downturn by 1-2 quarters. Further, the company has guided for a substantial decline in EBITDA in the fourth quarter, with the Titanium Technologies segment projected to experience a mid-high teens percentage drop, alongside weaker performance in Thermal & Specialized Solutions and stagnant results in Advanced Performance Materials. Additionally, mounting risks from declining TiO2 prices, regulatory slowdowns in demand for HFCs and HFOs, and weakening global macroeconomic conditions add further pressure to the company's financial stability.
This aggregate rating is based on analysts' research of Chemours and is not a guaranteed prediction by Public.com or investment advice.
Chemours (CC) Analyst Forecast & Price Prediction
Start investing in Chemours (CC)
Order type
Buy in
Order amount
Est. shares
0 shares